The U.S. Food and Drug Administration announced today that it is pulling back a proposed regulation that would have required manufacturers of talc‑containing cosmetics to conduct asbestos testing before products could be marketed.
The agency explained that it intends to develop a more comprehensive rule that better addresses the complexities of talc safety, supply‑chain oversight, and analytical methods. Officials said the current proposal was too narrow and could create unintended gaps in consumer protection.
Health‑advocacy groups expressed disappointment and concern. “For years we have fought to eliminate asbestos from consumer products, and this retreat feels like a step backward,” said Maria Alvarez, director of the Consumer Safety Coalition. Many organizations warned that without mandatory testing, products could still reach the market containing harmful levels of asbestos fibers.
Talc is a mineral widely used in powders, creams, and other personal‑care items for its smooth texture. However, natural talc deposits can be contaminated with asbestos, a known carcinogen linked to lung disease and mesothelioma when inhaled. Past investigations have uncovered asbestos in a small percentage of talc‑based cosmetics, prompting calls for stricter oversight.
The FDA said it will reopen its rulemaking process, inviting additional public comment and scientific input. The agency aims to issue a revised proposal later this year that could include:
Stakeholders—including manufacturers, consumer groups, and health experts—are expected to submit feedback during the upcoming comment period.
In the meantime, the FDA advises consumers to remain vigilant. Checking ingredient lists for the presence of talc and opting for products that are certified asbestos‑free can help mitigate potential risks. The agency also encourages reporting any adverse reactions or concerns to the FDA’s MedWatch program.